Projects per year
Fingerprint
Dive into the research topics where David M Dingli is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 1 Finished
-
Molecular imaging and system dynamics of tumor virotherapy
Dingli, D. M. (PI)
9/21/11 → 11/30/16
Project: Research project
-
Association of Thrombocytopenia With Disease Burden, High-Risk Cytogenetics, and Survival in Newly Diagnosed Multiple Myeloma Patients Treated With Novel Therapies
Charalampous, C., Goel, U., Kapoor, P., Binder, M., Buadi, F., Dingli, D., Dispenzieri, A., Fonder, A., Gertz, M., Gonsalves, W., Hayman, S., Hobbs, M., Hwa, Y. L., Kourelis, T., Lacy, M., Leung, N., Lin, Y., Warsame, R., Kyle, R. A. & Rajkumar, V. & 1 others, , Oct 2024, In: Clinical Lymphoma, Myeloma and Leukemia. 24, 10, p. e329-e335Research output: Contribution to journal › Article › peer-review
-
Clinical features associated with poor response and early relapse following BCMA-directed therapies in multiple myeloma
Rees, M. J., Mammadzadeh, A., Bolarinwa, A., Elhaj, M. E., Bohra, A., Bansal, R., Ailawadhi, S., Parrondo, R., Chhabra, S., Khot, A., Hayman, S., Dispenzieri, A., Buadi, F., Dingli, D., Warsame, R., Kapoor, P., Gertz, M. A., Muchtar, E., Kourelis, T. & Gonsalves, W. & 3 others, , Dec 2024, In: Blood cancer journal. 14, 1, 122.Research output: Contribution to journal › Article › peer-review
Open Access -
Clinician and administrator perspectives on outpatient administration of ciltacabtagene autoleucel in relapsed or refractory multiple myeloma
Hansen, D. K., Dhakal, B., Hamadani, M., Dingli, D., Jain, T., Huff, C. A., Janakiram, M., Liu, Y. H., De Braganca, K. C., Lodowski, N., Sander, J., Okorozo, P., McFarland, L., Perciavalle, M., Huo, S., Qureshi, Z. P. & Patel, K. K., 2024, In: Frontiers in immunology. 15, 1405452.Research output: Contribution to journal › Article › peer-review
Open Access -
Correction: Outcomes among newly diagnosed AL amyloidosis patients with a very high NT-proBNP: implications for trial design (Leukemia, (2021), 35, 12, (3604-3607), 10.1038/s41375-021-01297-z)
Vaxman, I., Kumar, S. K., Buadi, F., Lacy, M. Q., Dingli, D., Hwa, Y., Fonder, A., Hobbs, M., Hayman, S., Kourelis, T., Warsame, R., Muchtar, E., Leung, N., Kapoor, P., Grogan, M., Go, R., Lin, Y., Gonsalves, W., Siddiqui, M. & Kyle, R. A. & 3 others, , Aug 2024, In: Leukemia. 38, 8, p. 1866 1 p.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
Correction: Monoclonal proteinuria predicts progression risk in asymptomatic multiple myeloma with a free light chain ratio ≥100 (Leukemia, (2022), 36, 5, (1429-1431), 10.1038/s41375-022-01529-w)
Visram, A., Rajkumar, S. V., Kapoor, P., Dispenzieri, A., Lacy, M. Q., Gertz, M. A., Buadi, F. K., Hayman, S. R., Dingli, D., Kourelis, T., Gonsalves, W., Warsame, R., Muchtar, E., Leung, N., Kyle, R. A. & Kumar, S. K., Aug 2024, In: Leukemia. 38, 8, p. 1862 1 p.Research output: Contribution to journal › Comment/debate › peer-review